• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 42055120-080
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Stenosis (2263)
Event Date 11/21/2023
Event Type  Injury  
Event Description
It was reported that two supera stents (5.5x120 mm and 5.5x80 mm) were implanted on (b)(6), 2023.On (b)(6), 2023, the patient presented with severe claudication of the right leg and an angiogram confirmed a stent re-stenosis had occurred.No treatment has been provided at this time.No additional information was provided.
 
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect(s) of stenosis and pain is listed in the supera peripheral stent systems instructions for use as a known patient effect(s) of coronary procedures.A cine was received and reviewed by an abbott vascular clinical specialist: the radiographic images provided do show the reported occlusion in what appears to be the distal section of the previously deployed supera located in the distal superficial femoral artery (sfa).A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.B3 - date of event updated from 3/24/2023 to 11/21/2023.
 
Event Description
Subsequently to the initial filed emdr reported additional information was received: it was reported that both supera stents were implanted in the femoral popliteal artery.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18440305
MDR Text Key331859215
Report Number2024168-2024-00118
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/01/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/03/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number42055120-080
Device Lot Number2091661
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/22/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
5.5X80 MM SUPERA
Patient Outcome(s) Other;
Patient Age82 YR
Patient SexMale
Patient Weight80 KG
-
-